Toray Industries, Inc. is a leading Japanese manufacturer engaged in the integrated chemical industry, specializing in a wide range of products, including fibers and textiles, performance chemicals, carbon fiber composite materials, and life science products. Founded in 1926 and headquartered in Tokyo, the company has a strong global presence, operating in markets across Japan, China, North America, Europe, and beyond. Its offerings encompass filament yarns, staple fibers, and various fabrics made from nylon, polyester, and acrylics, as well as innovative materials like ultra-microfiber non-woven fabric. In addition to textiles, Toray produces a diverse array of plastics, resins, films, and electronic materials. The company is also involved in pharmaceuticals, medical devices, and engineering services, contributing to water treatment and civil engineering. Toray leverages advanced technologies, including nanotechnology and organic synthetic chemistry, to drive innovation and sustainability across its multiple business sectors, making it a key player in both the apparel and industrial materials markets.
TenCate Advanced Composites operates as a carbon fiber composite material manufacturer. TenCate Advanced Composites produces thermoplastic and thermoset solutions for aerospace, astrospace, commercial, industrial, microwave, satellites, communication and recreational applications. TenCate Advanced Composites began producing advanced composite materials in 1972, growing through a series of investments, acquisitions, and continuous ingenuity into the global company it is today. TenCate employs more than 750 employees worldwide, with manufacturing locations in North America, Europe, and Asia. Dedicated to innovation and industry leadership, TenCate specializes in multiple composite and carbon fiber materials and processes for the world's aerospace, space/satellite, high-performance automotive racing, high-end industrial, and athletic footwear markets.
BONAC specializes in research and development of nucleic acid medicines. Its services include nucleic acid drug substance manufacturing and drug development. The company was founded in 2010.
Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).
Spectral Medical focuses on the development and commercialization of a treatment for septic shock using its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic.
Alien Technology is a provider of reliable, high-volume, low cost, EPC compliant Radio Frequency Identification (RFID) products. Using Fluidic Self Assembly (FSA ), a patented manufacturing process, Alien manufactures electronic product code (EPC) class 1 tags and readers used in a variety of applications including supply chain management, logistics operations and anti-counterfeiting to improve inventory management and reduce operating costs. Alien Technology Corporation is an active member of EPC Global. More information about Alien Technology Corporation can be found on the Company's website at www.alientechnology.com. Alien, Alien Technology and FSA are trademarks or registered trademarks of Alien Technology Corporation in the United States and other countries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.